
A seasoned pharmaceutical leader with deep expertise in the Central Nervous System (CNS) segment, bringing a proven track record of building and transforming high-performance businesses in India. Successfully led Lundbeck India as Country Manager, driving a significant turnaround and earning recognition as the Best Country Manager in Southeast Asia.
Instrumental in launching and establishing first-in-class patented therapies, including Vortioxetine, and positioning the organisation among the fastest-growing CNS companies in India.
Demonstrated strong capability in market development, brand building, and therapy leadership in highly specialized segments.
At Cadila Pharmaceuticals, successfully rebuilt and scaled the CNS business, delivering sustained growth and strengthening field force effectiveness.
Known for strong engagement with key opinion leaders (KOLs) across India, driving scientific advocacy, and shaping prescription behaviour. Combines strategic vision with execution excellence to consistently deliver above-market growth in competitive and evolving CNS landscapes.
Former Chief Strategy Officer at Cadila Pharmaceuticals Ltd, operating at ₹1,500+ Cr scale and leading enterprise-wide transformation across multiple businesses